{"transactions":[{"id":784133,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48236,"kind":"person","name":"Glick Gary D","position":1,"cik":"0002051249","reported_name":"Glick Gary D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T00:30:06.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":884450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests in forty-eight (48) equal monthly installments, with the first installment scheduled to vest on June 7, 2026, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":884450,"derivative":{"exercise_price":18,"expiration_date":"2036-05-06","underlying":"Common Stock","underlying_shares":884450},"source":{"system":"sec-edgar","filing":"0001193125-26-217585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217585/ownership.xml","form_type":"4"}},{"id":784132,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48236,"kind":"person","name":"Glick Gary D","position":1,"cik":"0002051249","reported_name":"Glick Gary D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series D Convertible Preferred Stock","published_at":"2026-05-12T00:30:06.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":166116,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17095},"source":{"system":"sec-edgar","filing":"0001193125-26-217585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217585/ownership.xml","form_type":"4"}},{"id":784131,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48236,"kind":"person","name":"Glick Gary D","position":1,"cik":"0002051249","reported_name":"Glick Gary D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-05-12T00:30:06.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10291},"source":{"system":"sec-edgar","filing":"0001193125-26-217585","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217585/ownership.xml","form_type":"4"}},{"id":784130,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48236,"kind":"person","name":"Glick Gary D","position":1,"cik":"0002051249","reported_name":"Glick Gary D","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-05-12T00:30:06.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":27386,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration."}],"balance_after":415973,"source":{"system":"sec-edgar","filing":"0001193125-26-217585","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1882782/000119312526217585/ownership.xml","form_type":"4"}}]}